首页 | 本学科首页   官方微博 | 高级检索  
     

局部血管内低剂量促红细胞生成素和联合 tPA 注射对大鼠脑缺血的影响
引用本文:王荣亮,赵海苹,武晓宁,高金环,吉训明,罗玉敏. 局部血管内低剂量促红细胞生成素和联合 tPA 注射对大鼠脑缺血的影响[J]. 首都医科大学学报, 2014, 0(6): 748-754
作者姓名:王荣亮  赵海苹  武晓宁  高金环  吉训明  罗玉敏
作者单位:首都医科大学宣武医院脑血管病研究室,北京市老年病医疗研究中心,北京 100053
基金项目:国家自然科学基金(81071058
摘    要:目的:探讨局部血管内低剂量促红细胞生成素( erythropoietin,EPO)联合组织纤溶酶原激活剂( tissue plasminogen activator,tPA)注射是否可以降低 tPA 单独应用时的不良反应及机制。方法成年雄性 Sprague-Dawley 大鼠进行大脑中动脉闭塞手术,将健康雄性 SD 大鼠按数字表法随机分为5组,每组10只,分别缺血2 h 和4 h,再灌注30 min 后通过大脑中动脉单独注射 tPA,或联合注射 EPO(800 IU/ kg)及 tPA。结果局部血管内低剂量 EPO 联合 tPA 注射可以减小大鼠脑缺血再灌注24 h 后的病死率、改善神经功能、减少脑水肿和脑出血,并且没有产生血液学不良反应。局部血管内低剂量 EPO 联合 tPA 注射组与0.9%(质量分数)氯化钠注射液联合 tPA 注射组比较,p-AKT 和 p-ERK 的表达水平明显升高。结论大鼠脑缺血后,局部血管内低剂量 EPO 和 tPA 联合使用,可减少 tPA 单独使用时的不良反应,并发挥 EPO 的神经保护作用,可能与 AKT 和 ERK 通路激活有关。

关 键 词:促红细胞生成素  组织纤溶酶原激活剂  神经保护  脑缺血  再灌注

Effect of local intraarterial infusion of low-dose erythropoietin in combination with tissue plasminogen activator on focal cerebral ischemia in rats
Wang Rongliang,Zhao Haiping,Wu Xiaoning,Gao Jinhuan,Ji Xunming,Luo Yumin. Effect of local intraarterial infusion of low-dose erythropoietin in combination with tissue plasminogen activator on focal cerebral ischemia in rats[J]. Journal of Capital Medical University, 2014, 0(6): 748-754
Authors:Wang Rongliang  Zhao Haiping  Wu Xiaoning  Gao Jinhuan  Ji Xunming  Luo Yumin
Affiliation:( Cerebrovascular Diseases Research Institute, Xuanwu Hospital, Capital Medical University, Belting Geriatric Medical Research Center, Beijing 100053, China)
Abstract:Objective To investigate the effect of local intraarterial infusion of low-dose erythropoietin(EPO) in combination with tissue plasminogen activator(tPA) on focal cerebral ischemic stroke. Methods Adult male Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 2 or 4 h, followed by a tPA infusion over 30 min at the onset of reperfusion, with or without EPO(800 IU/ kg) infusion via middle cerebral artery. A total of 50 male rats were randomly divided into 5 groups. Results Local intraarterial infusion of low-dose EPO in combination with tPA protected against transient focal cerebral ischemia in rats, manifested by a decrease in mortality, neurological deficit scores, brain edema and hemorrhage with no hematological side effects after 24 h reperfusion. The levels of p-AKT and p-ERK were both increased in response to administration of EPO, suggesting a concurrent activation of AKT and ERK pathways. Conclusion Local intraarterial infusion of low-dose EPO in combination with tPA protected against focal cerebral ischemia in rats with no significant side effects, involving activation of AKT and ERK pathways.
Keywords:erythropoietin  tissue plasminogen activator  neuroprotection  cerebral ischemia  reperfusion
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号